【医药计算机】【资讯翻译】智能手机诊断程序CellScope app 开发获投1百万美元
发布于 2012-06-12 · 浏览 1027 · IP 江苏江苏
这个帖子发布于 12 年零 336 天前，其中的信息可能已发生改变或有所发展。
http://mobihealthnews.com/17598/cellscope-smartphone-diagnostic-startup-raises-1m/
认领翻译的战友请跟帖注明“认领本文翻译，48小时内未完成，请其他战友认领！
请根据自己专业背景选择认领，如使用翻译软件翻译，被发现者扣分1-2分
请根据自己的专业背景选择相应的资讯认领，经常认领而不能及时提供优质稿件者将被列入黑名单，取消认领资格，请大家注意！
新近参与本次活动的会员请查看：【公告】动态版重启资讯翻译计划：我为人人，人人为我，共同提高
寻找最近的翻译贴请查看：http://search.dxy.cn/?words=%E8%B5%84%E8%AE%AF%E7%BF%BB%E8%AF%91&bid=116&t=1&c=1&age=7&bid=116&limit=30&o=1
翻译时请参照版规 【版务】科技动态版版规及加分细则（ 2014-02-21 更新）
希望参与动态版其他活动的会员请查看版面右边栏的置顶部分
CellScope, smartphone diagnostic startup, raises $1M
Khosla Ventures, the investment firm headed up by noted venture capitalist and Sun Microsystems co-founder Vinod Khosla, is increasingly making investments in mobile health startups. Khosla Ventures has made three investments in mobile health companies in as many months. In April we noted that Khosla had contributed to Misfit Wearables’ $7.6 million second round of funding and just this morning we reported on Khosla leading the $10.5 million second round of funding for AliveCor.
Khosla Ventures also recently invested $1 million in CellScope, an alum from Rock Health’s first class of startups in 2011. The company is developing smartphone peripheral devices designed for consumers to use for at-home diagnosis.
Think of it as a “modern-day digital first aid kit.”
CellScope’s first offering will be a smartphone-enabled otoscope that will enable physicians to remotely diagnose ear infections in children. Parents will be able to use the peripheral, which attaches to a smartphone camera lens, to send an image of their child’s inner ear that physicians can use to make a diagnosis and then write a prescription if need be. CellScope says ear infections in children make up 30 million doctor visits annually in the US alone. The consumer device would help parents miss less work and potentially cut down on late night emergency room visits, according to the startup.
The startup traces its origins to bioengineering Professor Dan Fletcher’s lab at UC Berkeley, where CellScope founders Erik Douglas and Amy Sheng were developing cellphone-microscopy for remote diagnosis in developing countries. CellScope expects to launch future products focused on throat and skin exams, including non-clinical apps for consumer skincare.
Here’s how Fletcher, who has also advised the Obama Administration on science and technology in the past, described his work on CellScope, according to a MobiHealthNews report in mid-2009:
“A second opportunity for the government to promote mobile health is through sponsoring research and development. This, I’ll use an example from my own lab at Berkeley. The result was a simple attachment to a cell phone [called CellScope] that would allow you to take images of sputum samples or blood samples. We designed this and decided try and build it. It seems to give us reasonable results. This is an example of a blood smear on that phone and this is a sickle cell sample. Being able to do sickle cell screening in the field both abroad as well as in this country in lower resource areas has potential. Technologies in the distant future may enable use of this sort of imaging capability to take some of the back laboratory tests that need to be run and put those in the hands of patients or mobile health workers.”
“Health data, the key ingredient to useful analysis and diagnosis, is starting to explode exponentially – and CellScope is on the cutting edge,” Vinod Khosla said in a written statement. “Erik and his team are creating next-generation technology that will empower patients and help them access the best care in the most efficient manner possible.”
认领翻译的战友请跟帖注明“认领本文翻译，48小时内未完成，请其他战友认领！
请根据自己专业背景选择认领，如使用翻译软件翻译，被发现者扣分1-2分
请根据自己的专业背景选择相应的资讯认领，经常认领而不能及时提供优质稿件者将被列入黑名单，取消认领资格，请大家注意！
新近参与本次活动的会员请查看：【公告】动态版重启资讯翻译计划：我为人人，人人为我，共同提高
寻找最近的翻译贴请查看：http://search.dxy.cn/?words=%E8%B5%84%E8%AE%AF%E7%BF%BB%E8%AF%91&bid=116&t=1&c=1&age=7&bid=116&limit=30&o=1
翻译时请参照版规 【版务】科技动态版版规及加分细则（ 2014-02-21 更新）
希望参与动态版其他活动的会员请查看版面右边栏的置顶部分
CellScope, smartphone diagnostic startup, raises $1M
Khosla Ventures, the investment firm headed up by noted venture capitalist and Sun Microsystems co-founder Vinod Khosla, is increasingly making investments in mobile health startups. Khosla Ventures has made three investments in mobile health companies in as many months. In April we noted that Khosla had contributed to Misfit Wearables’ $7.6 million second round of funding and just this morning we reported on Khosla leading the $10.5 million second round of funding for AliveCor.
Khosla Ventures also recently invested $1 million in CellScope, an alum from Rock Health’s first class of startups in 2011. The company is developing smartphone peripheral devices designed for consumers to use for at-home diagnosis.
Think of it as a “modern-day digital first aid kit.”
CellScope’s first offering will be a smartphone-enabled otoscope that will enable physicians to remotely diagnose ear infections in children. Parents will be able to use the peripheral, which attaches to a smartphone camera lens, to send an image of their child’s inner ear that physicians can use to make a diagnosis and then write a prescription if need be. CellScope says ear infections in children make up 30 million doctor visits annually in the US alone. The consumer device would help parents miss less work and potentially cut down on late night emergency room visits, according to the startup.
The startup traces its origins to bioengineering Professor Dan Fletcher’s lab at UC Berkeley, where CellScope founders Erik Douglas and Amy Sheng were developing cellphone-microscopy for remote diagnosis in developing countries. CellScope expects to launch future products focused on throat and skin exams, including non-clinical apps for consumer skincare.
Here’s how Fletcher, who has also advised the Obama Administration on science and technology in the past, described his work on CellScope, according to a MobiHealthNews report in mid-2009:
“A second opportunity for the government to promote mobile health is through sponsoring research and development. This, I’ll use an example from my own lab at Berkeley. The result was a simple attachment to a cell phone [called CellScope] that would allow you to take images of sputum samples or blood samples. We designed this and decided try and build it. It seems to give us reasonable results. This is an example of a blood smear on that phone and this is a sickle cell sample. Being able to do sickle cell screening in the field both abroad as well as in this country in lower resource areas has potential. Technologies in the distant future may enable use of this sort of imaging capability to take some of the back laboratory tests that need to be run and put those in the hands of patients or mobile health workers.”
“Health data, the key ingredient to useful analysis and diagnosis, is starting to explode exponentially – and CellScope is on the cutting edge,” Vinod Khosla said in a written statement. “Erik and his team are creating next-generation technology that will empower patients and help them access the best care in the most efficient manner possible.”
最后编辑于 2022-10-09 · 浏览 1027
5 收藏点赞
